Junjun Xu

4PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)PharmacogenomicsNursing workforce
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Tivozanib versus Sorafenib as Subsequent-Line Therapy for Advanced Renal Cell Carcinoma: A Cost-Effectiveness Analysis from a US Healthcare Perspective.

|Aug 24, 2025
CYP2C19 genotype-guided antiplatelet therapy to prevent thromboembolic events after stent-assisted coil embolization of unruptured intracranial aneurysms: a retrospective cohort study.

Mingdong Yang, Xiaoyu Zhang, Junjun Xu

|Sep 26, 2024
Population pharmacokinetics of nirmatrelvir/ritonavir in critically ill Chinese COVID-19 patients and recommendations for medication use: a two-center retrospective study.

Junjun Xu, Jinmeng Li, Meng Chen

|Jul 01, 2024
Building a Hospital Pharmacist Workforce by a Diversified and Position-Oriented Learning System.

Wei He, Yangmin Hu, Difei Yao

Pageof 1

Frequent Collaborators

2 joint publications

Haibin Dai

2 joint publications

Mingdong Yang

1 joint publications

Xiaoyu Zhang

1 joint publications

Ruming Liu